Not Yet RecruitingNCT05628610
Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer
PHASE2 · 130 planned enrolment
- Countries listed
- 0
- Registry update
- August 13, 2024
Registry Intervention View
Tislelizumab
Trial registrations containing the exact intervention label Tislelizumab.
Exact registry label · Not reported
2 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
0 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
UnknownNCT05273814
Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer
PHASE1 · 30 planned enrolment
- Countries listed
- 1
- Registry update
- July 13, 2022